Nikova Bispham
Family · Falls Church, VANPI 1477805596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 165 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,028 and has fallen 70.9% since, to $299 in 2025. Among family clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 165 payments — averaging $20.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lundbeck LLC$355
- Harmony Biosciences LLC$334
- AbbVie$326
- UCB, Inc.$306
- Lilly USA, LLC$252
- Novartis$233
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,20097%
- Education$1053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lundbeck LLC | 15 | $355 |
| Harmony Biosciences LLC | 15 | $334 |
| AbbVie | 15 | $326 |
| UCB, Inc. | 13 | $306 |
| Lilly USA, LLC | 14 | $252 |
| Novartis | 12 | $233 |
| Eisai Inc. | 10 | $185 |
| Sumitomo Pharma America, Inc. | 11 | $170 |
| Biogen | 9 | $165 |
| Jazz Pharmaceuticals Inc. | 8 | $127 |
| Neurelis, Inc. | 7 | $115 |
| Teva Pharmaceuticals USA, Inc. | 2 | $107 |
| Sunovion Pharmaceuticals Inc. | 6 | $102 |
| Neurocrine Biosciences, Inc. | 4 | $95 |
| EMD Serono, Inc. | 4 | $71 |
| Amgen | 2 | $62 |
| Biohaven Pharmaceuticals, Inc. | 3 | $39 |
| Amneal Pharmaceuticals LLC | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $33 |
| Impel Pharmaceuticals Inc. | 2 | $30 |
| Upsher-smith Laboratories LLC | 2 | $30 |
| Bristol Myers Squibb | 2 | $28 |
| Argenx US, Inc. | 1 | $26 |
| Insightec,inc | 1 | $21 |
| Livanova USA, Inc. | 1 | $18 |
| SK Life Science, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
How this compares
$3,305 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 23 | $490 |
Paid to pharmacies, not to this prescriber.
Other family in Falls Church
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.